'Use of selective serotonin reuptake inhibitors in children with pervasive developmental disorder: risk of treatment emergent mania'.
Bates
Gordon
G
Willson
Susie Wynne
SW
D000367:Age Factors; D001714:Bipolar Disorder / Q000139:chemically induced / Q000517:prevention & control; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors